
Available via
WEBINAR
Frontiers in Cancer Immunotherapy
Tuesday, May 14, 2019, 8:00 AM - Wednesday, May 15, 2019, 5:30 PM EDT
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Immuno-oncology promises a revolution in the way we treat cancer. Since the approval of the first checkpoint inhibitors in 2014, and the subsequent approval of the first cellular therapy in 2017, the field of cancer immunotherapy has exploded with numerous ongoing clinical trials. Despite great successes, emerging results suggest that monotherapies are not sufficient to treat many cancer types and it is increasingly clear that combinatorial approaches are needed to target heterogeneous tumors and improve variability in patient response.
This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies. Particular emphasis will be given to the biological mechanisms underlying combination hypotheses, bispecific antibodies and other emerging modalities for delivery of combination therapies, as well as a discussion of the importance of biomarkers and effective clinical trial design.
Registration
Member
By 04/02/2019
$250
After 04/02/2019
$340
Nonmember Academia, Faculty, etc.
By 04/02/2019
$400
After 04/02/2019
$540
Nonmember Corporate, Other
By 04/02/2019
$475
After 04/02/2019
$640
Nonmember Not for Profit
By 04/02/2019
$400
After 04/02/2019
$540
Nonmember Student, Undergrad, Grad, Fellow
By 04/02/2019
$270
After 04/02/2019
$365
Member Student, Post-Doc, Fellow
By 04/02/2019
$220
After 04/02/2019
$300
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15
Member
$60
Nonmember Academia, Faculty, etc.
$130
Nonmember Corporate, Other
$170
Nonmember Not for Profit
$130
Nonmember Student, Undergrad, Grad, Fellow
$90
Member Student, Post-Doc, Fellow
$30
Event Sponsors
Silver
Bronze
Academy Friends
This event is supported by grants from:
Promotional Partners
Program Supporters
Cancer Discussion Group Lead Supporter
Cancer Discussion Group Supporter
Tuesday
May 14, 2019
8:00 AM
Breakfast and Registration
9:00 AM
Introduction and Welcome Remarks
Speakers
Sonya Dougal, PhD
The New York Academy of Sciences
Chris Boshoff, MD, PhD
Pfizer
Session 1
Session Chairperson
Chris Boshoff, MD, PhD, Pfizer
9:15 AM
Immune Checkpoint Blockade: Blurring the Line between Autoimmunity and Tumor Immunity
Speaker
Jedd Wolchok, MD, PhD
Memorial Sloan Kettering Cancer Center
10:00 AM
From the Clinic to the Lab: Investigating Response and Resistance Mechanisms to Immune Checkpoint Therapy
Speaker
Padmanee Sharma, MD, PhD
MD Anderson Cancer Center
10:30 AM
Panel Discussion: Innovative Approaches in Clinical Trial Design
Speakers
Jedd Wolchok, MD, PhD (moderator)
Memorial Sloan Kettering Cancer Center
Donald A Berry, PhD
MD Anderson Cancer Center
Adnan Jaigirdar, MD, FACS
Food and Drug Administration
Samit Hirawat, MD
Novartis
Padmanee Sharma, MD, PhD
MD Anderson Cancer Center
11:15 AM
Networking Coffee Break
11:45 AM
Epigenetic Regulation of Tumor-Associated Myeloid Cells
Speaker
Jane Grogan, PhD
Genentech
12:15 PM
BCMA Targeted Immunotherapy for Multiple Myeloma
Speaker
Kristen Hege, MD
Celgene
12:45 PM
Networking Lunch and Poster Session
Speaker
Even Numbered Posters: 1:15 PM - 2:00 PM
Session 2
Session Chairperson
George Zavoico, PhD, B. Riley FBR
2:00 PM
Tumor Antigens and the Immune System
Speaker
Lisa H. Butterfield, PhD
The Parker Institute for Cancer Immunotherapy
2:45 PM
PD-L1 Probody Therapeutics
Speaker
Rachel Humphrey, MD
CytomX
3:15 PM
Networking Coffee Break
3:45 PM
Targeting Tumors with T Cells Engineered to Overcome Therapeutic Obstacles
Speaker
Philip Greenberg, MD
Fred Hutchinson Cancer Research Center
4:30 PM
Day 1 Wrap Remarks
Speaker
George Zavoico, PhD
B. Riley FBR
4:35 PM
Networking Reception and Poster Session
Speaker
Odd Numbered Posters: 4:45 PM - 5:30 PM
5:30 PM
Day 1 Adjourns
Wednesday
May 15, 2019
8:00 AM
Breakfast and Registration
8:00 AM
Career Development Breakfast for Graduate Students and Post-docs
9:00 AM
Welcome Remarks
Speaker
Sara Donnelly, PhD
The New York Academy of Sciences
Session 3
Session Chairperson
Rachel Humphrey, MD, CytomX
9:15 AM
In Situ Vaccination for Cancer
Speaker
Ronald Levy, MD
Stanford University
10:00 AM
Microbiota and Anti-Tumor Immunity
Speaker
Thomas Gajewski, MD, PhD
University of Chicago
10:30 AM
Networking Coffee Break
11:00 AM
Radiation in Combination with Checkpoint Inhibitors
Speaker
Silvia C. Formenti, MD
Weill Cornell Medical College
11:30 AM
Data Blitz - Role of Notch Signaling on Human Dendritic Cell Subset Differentiation
Speaker
Sreekumar Balan, PhD
Icahn School of Medicine at Mount Sinai
11:35 AM
Data Blitz - Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
Speaker
Yuxuan Miao, PhD
The Rockefeller University
11:40 AM
Data Blitz - Induction of the Senescence-Associated Secretory Phenotype Makes “Cold” Pancreas Tumors “Hot” and Potentiates PD-1 Blockade Immunotherapy
Speaker
Marcus Ruscetti, PhD
Memorial Sloan Kettering Cancer Center
11:45 AM
Networking Lunch
Session 4: Breakout Track A**
Session Chairperson
George Zavoico, PhD, B. Riley FBR (**this session will not be part of the webinar)
1:00 PM
Novel Approaches from Biotech
Speakers
Anish Suri, PhD
Cue Biopharma
Frederic Triebel, MD, PhD
Immutep Ltd.
Laurent Levy, PhD
Nanobiotix
Maya Kotturi, PhD
Compugen
Session 4: Breakout Track B
Session Chairperson
Chris Boshoff, MD, PhD, Pfizer
1:00 PM
Targeting Solid Tumors with Immunotherapy
Speakers
Renier Brentjens, MD, PhD
Memorial Sloan Kettering Cancer Center
Amit Kumar, PhD
Anixa Biosciences
Maria Fardis, PhD, MBA
Iovance Biotherapeutics
Session 5
2:00 PM
Targeting Macrophage Mediated Immune Suppression to Promote Effective Cancer Immune Therapy
Speaker
Judith Varner, PhD
University of California San Diego School of Medicine
2:30 PM
Neutrophil Extracellular Traps Produced During Inflammation Awaken Dormant Cancer Cells
Speaker
Jean Albrengues, PhD
Cold Spring Harbor Laboratory
3:00 PM
Networking Coffee Break
3:30 PM
Cellular Immunotherapy for Common Epithelial Cancers
Speaker
James Yang, MD
National Cancer Institute
4:00 PM
Keynote ~ Immune Checkpoint Blockade in Cancer Therapy: Historical Perspective, New Opportunities
Speaker
James Allison, PhD
MD Anderson Cancer Center
4:45 PM
Closing Remarks
Speaker
Renier Brentjens, MD, PhD
Memorial Sloan Kettering Cancer Center
5:00 PM